Concepts (258)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Rectal Neoplasms | 11 | 2021 | 1183 | 2.280 |
Why?
|
Colorectal Surgery | 6 | 2020 | 125 | 2.150 |
Why?
|
Anus Neoplasms | 4 | 2021 | 336 | 1.600 |
Why?
|
Appendectomy | 9 | 2024 | 445 | 1.520 |
Why?
|
Digestive System Surgical Procedures | 7 | 2021 | 584 | 1.320 |
Why?
|
Neuroendocrine Tumors | 3 | 2019 | 659 | 1.200 |
Why?
|
Laparoscopy | 5 | 2023 | 2038 | 1.150 |
Why?
|
Colon | 5 | 2024 | 1797 | 1.060 |
Why?
|
Appendiceal Neoplasms | 4 | 2019 | 155 | 1.000 |
Why?
|
Rectum | 5 | 2024 | 897 | 0.990 |
Why?
|
Colectomy | 6 | 2021 | 696 | 0.920 |
Why?
|
Surgical Wound Infection | 8 | 2023 | 1547 | 0.920 |
Why?
|
Bupivacaine | 2 | 2019 | 414 | 0.910 |
Why?
|
Abdominal Muscles | 3 | 2020 | 172 | 0.900 |
Why?
|
Abdominal Abscess | 3 | 2023 | 152 | 0.880 |
Why?
|
Hyperthermia, Induced | 3 | 2021 | 414 | 0.790 |
Why?
|
Neoplasm Staging | 14 | 2021 | 11218 | 0.770 |
Why?
|
Negative-Pressure Wound Therapy | 2 | 2020 | 156 | 0.740 |
Why?
|
Appendicitis | 4 | 2023 | 680 | 0.730 |
Why?
|
Perineum | 2 | 2019 | 212 | 0.720 |
Why?
|
Length of Stay | 12 | 2021 | 6491 | 0.700 |
Why?
|
Pain, Postoperative | 5 | 2020 | 1768 | 0.670 |
Why?
|
Treatment Refusal | 2 | 2020 | 433 | 0.670 |
Why?
|
Peritoneal Neoplasms | 3 | 2021 | 706 | 0.650 |
Why?
|
Postoperative Complications | 17 | 2024 | 15831 | 0.650 |
Why?
|
Chemotherapy, Cancer, Regional Perfusion | 1 | 2019 | 94 | 0.650 |
Why?
|
Abdomen | 4 | 2020 | 1137 | 0.650 |
Why?
|
Lymph Nodes | 3 | 2020 | 3468 | 0.640 |
Why?
|
Colonic Neoplasms | 3 | 2020 | 2535 | 0.640 |
Why?
|
Antineoplastic Combined Chemotherapy Protocols | 5 | 2021 | 11876 | 0.620 |
Why?
|
Databases, Factual | 11 | 2021 | 8065 | 0.610 |
Why?
|
Adenocarcinoma, Mucinous | 2 | 2019 | 523 | 0.610 |
Why?
|
Carcinoma, Large Cell | 1 | 2019 | 114 | 0.610 |
Why?
|
Carcinoid Tumor | 1 | 2019 | 225 | 0.590 |
Why?
|
Survival Rate | 15 | 2021 | 12826 | 0.580 |
Why?
|
Antibiotic Prophylaxis | 2 | 2020 | 641 | 0.580 |
Why?
|
Intestinal Neoplasms | 1 | 2020 | 314 | 0.570 |
Why?
|
Databases as Topic | 1 | 2019 | 472 | 0.550 |
Why?
|
Abdominal Injuries | 1 | 2020 | 362 | 0.550 |
Why?
|
Crohn Disease | 2 | 2020 | 2286 | 0.540 |
Why?
|
Carcinoma, Small Cell | 1 | 2019 | 419 | 0.540 |
Why?
|
Anal Canal | 1 | 2019 | 375 | 0.520 |
Why?
|
Carcinoma, Squamous Cell | 3 | 2021 | 4050 | 0.500 |
Why?
|
Malpractice | 1 | 2020 | 561 | 0.490 |
Why?
|
Analgesics, Opioid | 6 | 2020 | 3837 | 0.480 |
Why?
|
Carcinoma, Neuroendocrine | 1 | 2019 | 343 | 0.480 |
Why?
|
Propensity Score | 4 | 2020 | 1972 | 0.430 |
Why?
|
Infection Control | 1 | 2020 | 984 | 0.420 |
Why?
|
Colorectal Neoplasms | 7 | 2021 | 6965 | 0.410 |
Why?
|
Chemotherapy, Adjuvant | 3 | 2020 | 3552 | 0.410 |
Why?
|
Adenocarcinoma | 6 | 2020 | 6359 | 0.400 |
Why?
|
Anesthesia, Spinal | 1 | 2015 | 280 | 0.390 |
Why?
|
Neoplasm Recurrence, Local | 3 | 2020 | 9407 | 0.370 |
Why?
|
Health Status Disparities | 2 | 2020 | 1880 | 0.370 |
Why?
|
Preoperative Care | 1 | 2020 | 2253 | 0.360 |
Why?
|
Postoperative Period | 7 | 2020 | 1824 | 0.360 |
Why?
|
Anastomosis, Surgical | 4 | 2024 | 992 | 0.350 |
Why?
|
Middle Aged | 45 | 2024 | 223267 | 0.340 |
Why?
|
Tumor Necrosis Factor-alpha | 2 | 2019 | 4349 | 0.340 |
Why?
|
Tourniquets | 2 | 2024 | 111 | 0.330 |
Why?
|
Follow-Up Studies | 10 | 2019 | 39312 | 0.320 |
Why?
|
Humans | 80 | 2024 | 766812 | 0.310 |
Why?
|
Combined Modality Therapy | 5 | 2021 | 8540 | 0.300 |
Why?
|
Carcinoma | 1 | 2019 | 2325 | 0.300 |
Why?
|
Anesthetics, Local | 1 | 2015 | 1005 | 0.300 |
Why?
|
Nerve Block | 1 | 2015 | 717 | 0.300 |
Why?
|
Retrospective Studies | 32 | 2024 | 81657 | 0.290 |
Why?
|
Anesthesia, General | 1 | 2015 | 1188 | 0.290 |
Why?
|
Healthcare Disparities | 2 | 2020 | 3411 | 0.280 |
Why?
|
Male | 46 | 2024 | 364154 | 0.270 |
Why?
|
Neoplasm Invasiveness | 3 | 2020 | 3610 | 0.270 |
Why?
|
Female | 49 | 2024 | 396532 | 0.270 |
Why?
|
Hip Fractures | 1 | 2015 | 996 | 0.270 |
Why?
|
Hepatectomy | 3 | 2021 | 589 | 0.270 |
Why?
|
Aged | 29 | 2024 | 171344 | 0.270 |
Why?
|
Perioperative Care | 3 | 2019 | 1043 | 0.270 |
Why?
|
Anastomotic Leak | 3 | 2018 | 170 | 0.260 |
Why?
|
Sepsis | 2 | 2018 | 2604 | 0.250 |
Why?
|
Opioid-Related Disorders | 2 | 2020 | 2188 | 0.250 |
Why?
|
United States | 20 | 2021 | 72945 | 0.220 |
Why?
|
Morphine | 2 | 2019 | 658 | 0.210 |
Why?
|
Skilled Nursing Facilities | 2 | 2019 | 406 | 0.210 |
Why?
|
Practice Guidelines as Topic | 1 | 2020 | 7430 | 0.200 |
Why?
|
Survival Analysis | 3 | 2020 | 10101 | 0.200 |
Why?
|
Leadership | 2 | 2022 | 1394 | 0.200 |
Why?
|
Incidence | 8 | 2021 | 21527 | 0.190 |
Why?
|
Arthroplasty, Replacement, Knee | 4 | 2017 | 1389 | 0.190 |
Why?
|
Faculty, Medical | 2 | 2020 | 1226 | 0.190 |
Why?
|
Prescriptions | 2 | 2020 | 388 | 0.180 |
Why?
|
Pulmonary Disease, Chronic Obstructive | 1 | 2015 | 3246 | 0.180 |
Why?
|
Aged, 80 and over | 10 | 2020 | 59548 | 0.180 |
Why?
|
Treatment Outcome | 16 | 2021 | 65286 | 0.180 |
Why?
|
Prognosis | 6 | 2020 | 29959 | 0.170 |
Why?
|
Hernia, Ventral | 1 | 2023 | 220 | 0.170 |
Why?
|
Duodenal Neoplasms | 1 | 2020 | 114 | 0.170 |
Why?
|
Melanoma | 1 | 2018 | 5702 | 0.170 |
Why?
|
Health Facility Size | 1 | 2019 | 59 | 0.170 |
Why?
|
Insurance, Liability | 1 | 2020 | 100 | 0.170 |
Why?
|
Professional Autonomy | 1 | 2020 | 172 | 0.160 |
Why?
|
Sigmoidoscopy | 1 | 2019 | 150 | 0.160 |
Why?
|
Liability, Legal | 1 | 2020 | 209 | 0.160 |
Why?
|
Pelvic Neoplasms | 1 | 2020 | 249 | 0.150 |
Why?
|
Absenteeism | 1 | 2020 | 247 | 0.150 |
Why?
|
Omentum | 1 | 2019 | 168 | 0.150 |
Why?
|
Career Mobility | 1 | 2020 | 262 | 0.150 |
Why?
|
Disinfection | 1 | 2020 | 207 | 0.150 |
Why?
|
Biology | 1 | 2020 | 292 | 0.150 |
Why?
|
Ileum | 1 | 2020 | 558 | 0.140 |
Why?
|
Rehabilitation Centers | 1 | 2019 | 249 | 0.140 |
Why?
|
Hernia, Inguinal | 1 | 2020 | 224 | 0.140 |
Why?
|
Health Plan Implementation | 1 | 2020 | 337 | 0.140 |
Why?
|
Cathartics | 1 | 2018 | 129 | 0.140 |
Why?
|
Esophageal Diseases | 1 | 2018 | 167 | 0.140 |
Why?
|
Intestine, Small | 2 | 2020 | 1217 | 0.140 |
Why?
|
tat Gene Products, Human Immunodeficiency Virus | 1 | 2017 | 119 | 0.140 |
Why?
|
Drug Therapy | 1 | 2020 | 504 | 0.140 |
Why?
|
Workplace | 2 | 2020 | 873 | 0.140 |
Why?
|
Leiomyosarcoma | 1 | 2020 | 426 | 0.130 |
Why?
|
Neurotoxins | 1 | 2017 | 240 | 0.130 |
Why?
|
Patient Discharge | 3 | 2019 | 3466 | 0.130 |
Why?
|
Ukraine | 3 | 2021 | 151 | 0.130 |
Why?
|
Liposomes | 1 | 2019 | 787 | 0.130 |
Why?
|
Ileostomy | 1 | 2016 | 122 | 0.130 |
Why?
|
Job Satisfaction | 1 | 2019 | 548 | 0.130 |
Why?
|
Adult | 21 | 2024 | 223305 | 0.130 |
Why?
|
Esophagectomy | 1 | 2019 | 478 | 0.130 |
Why?
|
Arthroplasty, Replacement, Hip | 2 | 2016 | 1417 | 0.120 |
Why?
|
Mesothelioma | 1 | 2021 | 774 | 0.120 |
Why?
|
Prospective Studies | 6 | 2019 | 54872 | 0.120 |
Why?
|
Hysterectomy | 1 | 2020 | 863 | 0.120 |
Why?
|
Academic Medical Centers | 2 | 2022 | 2783 | 0.120 |
Why?
|
Colonic Polyps | 1 | 2019 | 557 | 0.120 |
Why?
|
Surgical Stapling | 1 | 2015 | 98 | 0.110 |
Why?
|
Drug Utilization | 1 | 2020 | 1188 | 0.110 |
Why?
|
Nose | 1 | 2017 | 522 | 0.110 |
Why?
|
World Health Organization | 1 | 2020 | 1327 | 0.110 |
Why?
|
Risk Factors | 11 | 2024 | 74889 | 0.110 |
Why?
|
Quality Improvement | 3 | 2018 | 3850 | 0.100 |
Why?
|
Intestinal Obstruction | 1 | 2016 | 433 | 0.100 |
Why?
|
Obesity, Morbid | 1 | 2023 | 1292 | 0.100 |
Why?
|
Salvage Therapy | 1 | 2019 | 1274 | 0.100 |
Why?
|
Appointments and Schedules | 1 | 2016 | 442 | 0.100 |
Why?
|
Hemorrhage | 1 | 2024 | 3464 | 0.100 |
Why?
|
Prostatectomy | 1 | 2020 | 1785 | 0.100 |
Why?
|
Patient Transfer | 1 | 2019 | 789 | 0.100 |
Why?
|
Amyloid | 1 | 2017 | 849 | 0.100 |
Why?
|
Multivariate Analysis | 4 | 2020 | 12064 | 0.090 |
Why?
|
Gastrointestinal Agents | 1 | 2016 | 511 | 0.090 |
Why?
|
Drainage | 1 | 2017 | 1182 | 0.090 |
Why?
|
Methicillin-Resistant Staphylococcus aureus | 1 | 2017 | 705 | 0.090 |
Why?
|
Age Factors | 4 | 2020 | 18397 | 0.090 |
Why?
|
Lymphoma | 1 | 2020 | 1899 | 0.090 |
Why?
|
Proportional Hazards Models | 3 | 2020 | 12536 | 0.090 |
Why?
|
Burnout, Professional | 1 | 2019 | 710 | 0.090 |
Why?
|
Patient Readmission | 6 | 2021 | 3283 | 0.090 |
Why?
|
Surgical Flaps | 1 | 2019 | 1680 | 0.090 |
Why?
|
Hospitalization | 2 | 2020 | 10816 | 0.090 |
Why?
|
Suture Techniques | 1 | 2015 | 775 | 0.080 |
Why?
|
Staphylococcus aureus | 1 | 2017 | 1429 | 0.080 |
Why?
|
Time Factors | 3 | 2020 | 40149 | 0.080 |
Why?
|
Body Mass Index | 2 | 2024 | 13050 | 0.080 |
Why?
|
Arrhythmias, Cardiac | 1 | 2019 | 2257 | 0.080 |
Why?
|
General Surgery | 1 | 2020 | 1720 | 0.080 |
Why?
|
Wound Healing | 1 | 2020 | 2800 | 0.080 |
Why?
|
Hospitals, Community | 2 | 2021 | 363 | 0.080 |
Why?
|
Staphylococcal Infections | 1 | 2017 | 1396 | 0.080 |
Why?
|
Cross Infection | 1 | 2017 | 1427 | 0.080 |
Why?
|
Monitoring, Intraoperative | 1 | 2015 | 947 | 0.080 |
Why?
|
Patient Selection | 1 | 2020 | 4252 | 0.080 |
Why?
|
Referral and Consultation | 1 | 2021 | 3618 | 0.070 |
Why?
|
Liver Neoplasms | 2 | 2021 | 4356 | 0.070 |
Why?
|
Societies, Medical | 1 | 2020 | 3957 | 0.070 |
Why?
|
Acute Kidney Injury | 1 | 2019 | 1946 | 0.070 |
Why?
|
Socioeconomic Factors | 1 | 2020 | 7841 | 0.070 |
Why?
|
Health Status | 1 | 2019 | 4087 | 0.070 |
Why?
|
Skin | 1 | 2020 | 4499 | 0.070 |
Why?
|
Recurrence | 1 | 2019 | 8507 | 0.070 |
Why?
|
Venous Thrombosis | 1 | 2015 | 1321 | 0.060 |
Why?
|
Inflammatory Bowel Diseases | 2 | 2020 | 2429 | 0.060 |
Why?
|
Logistic Models | 2 | 2019 | 13276 | 0.060 |
Why?
|
Osteoarthritis, Knee | 1 | 2015 | 1251 | 0.060 |
Why?
|
Orthopedic Procedures | 1 | 2015 | 1279 | 0.060 |
Why?
|
Pain Measurement | 1 | 2015 | 3576 | 0.060 |
Why?
|
Balloon Occlusion | 1 | 2024 | 129 | 0.050 |
Why?
|
Hemostatic Techniques | 1 | 2024 | 116 | 0.050 |
Why?
|
Amyloid beta-Peptides | 1 | 2017 | 3886 | 0.050 |
Why?
|
Immunotherapy | 1 | 2019 | 4747 | 0.050 |
Why?
|
Obesity | 1 | 2024 | 13090 | 0.050 |
Why?
|
Pulmonary Embolism | 1 | 2015 | 2596 | 0.050 |
Why?
|
Vascular System Injuries | 1 | 2024 | 247 | 0.050 |
Why?
|
Double-Blind Method | 1 | 2015 | 12430 | 0.050 |
Why?
|
Economics, Nursing | 1 | 2020 | 7 | 0.040 |
Why?
|
United States Department of Defense | 1 | 2020 | 36 | 0.040 |
Why?
|
Economics, Pharmaceutical | 1 | 2020 | 88 | 0.040 |
Why?
|
Chernobyl Nuclear Accident | 1 | 2019 | 15 | 0.040 |
Why?
|
Abscess | 1 | 2023 | 606 | 0.040 |
Why?
|
Anti-Bacterial Agents | 1 | 2018 | 7475 | 0.040 |
Why?
|
Mitomycin | 1 | 2019 | 261 | 0.040 |
Why?
|
Qualitative Research | 2 | 2020 | 3138 | 0.040 |
Why?
|
Perioperative Period | 1 | 2020 | 252 | 0.040 |
Why?
|
Diagnosis-Related Groups | 1 | 2020 | 445 | 0.040 |
Why?
|
Young Adult | 6 | 2021 | 59939 | 0.040 |
Why?
|
Preoperative Period | 1 | 2020 | 564 | 0.040 |
Why?
|
Surgical Wound Dehiscence | 1 | 2019 | 215 | 0.040 |
Why?
|
Emergencies | 1 | 2024 | 1223 | 0.040 |
Why?
|
Recovery of Function | 2 | 2018 | 2978 | 0.040 |
Why?
|
Equipment and Supplies | 1 | 2020 | 273 | 0.040 |
Why?
|
Professional Competence | 1 | 2020 | 429 | 0.040 |
Why?
|
Circular Dichroism | 1 | 2017 | 333 | 0.030 |
Why?
|
Microscopy, Atomic Force | 1 | 2017 | 250 | 0.030 |
Why?
|
Intestinal Diseases | 1 | 2021 | 506 | 0.030 |
Why?
|
Reoperation | 2 | 2018 | 4325 | 0.030 |
Why?
|
Sex Factors | 2 | 2020 | 10619 | 0.030 |
Why?
|
Antibiotics, Antineoplastic | 1 | 2019 | 678 | 0.030 |
Why?
|
Ventilator Weaning | 1 | 2016 | 170 | 0.030 |
Why?
|
Hospitals | 2 | 2020 | 3885 | 0.030 |
Why?
|
Cross-Sectional Studies | 3 | 2021 | 26309 | 0.030 |
Why?
|
Patients | 1 | 2020 | 908 | 0.030 |
Why?
|
Protein Structure, Secondary | 1 | 2017 | 1211 | 0.030 |
Why?
|
Operating Rooms | 1 | 2020 | 790 | 0.030 |
Why?
|
Canada | 1 | 2019 | 2126 | 0.030 |
Why?
|
Age Distribution | 1 | 2019 | 2869 | 0.030 |
Why?
|
Minority Groups | 1 | 2020 | 1208 | 0.030 |
Why?
|
Emergency Medical Services | 1 | 2024 | 1936 | 0.030 |
Why?
|
Fluorescent Antibody Technique | 1 | 2017 | 2470 | 0.030 |
Why?
|
Adolescent | 4 | 2021 | 88902 | 0.020 |
Why?
|
Diagnostic Tests, Routine | 1 | 2017 | 788 | 0.020 |
Why?
|
Wounds and Injuries | 1 | 2024 | 2513 | 0.020 |
Why?
|
Neoplasms | 1 | 2019 | 22350 | 0.020 |
Why?
|
Neoadjuvant Therapy | 1 | 2021 | 2902 | 0.020 |
Why?
|
Blood Transfusion | 1 | 2016 | 1308 | 0.020 |
Why?
|
Motivation | 1 | 2019 | 2020 | 0.020 |
Why?
|
Anesthesia | 1 | 2020 | 1595 | 0.020 |
Why?
|
Morbidity | 1 | 2014 | 1754 | 0.020 |
Why?
|
Kaplan-Meier Estimate | 1 | 2019 | 6514 | 0.020 |
Why?
|
Neoplasm Metastasis | 1 | 2019 | 4892 | 0.020 |
Why?
|
Feasibility Studies | 1 | 2019 | 5306 | 0.020 |
Why?
|
Insurance, Health | 1 | 2020 | 2520 | 0.020 |
Why?
|
ROC Curve | 1 | 2015 | 3621 | 0.020 |
Why?
|
Cohort Studies | 2 | 2020 | 41706 | 0.020 |
Why?
|
Knee Joint | 1 | 2015 | 1682 | 0.020 |
Why?
|
Rats, Sprague-Dawley | 1 | 2017 | 8108 | 0.020 |
Why?
|
Lung Diseases | 1 | 2016 | 1940 | 0.020 |
Why?
|
Decision Making | 1 | 2019 | 3951 | 0.020 |
Why?
|
Protein Binding | 1 | 2017 | 9326 | 0.010 |
Why?
|
Radiography | 1 | 2015 | 6968 | 0.010 |
Why?
|
Mice, Transgenic | 1 | 2017 | 9546 | 0.010 |
Why?
|
Inpatients | 1 | 2016 | 2566 | 0.010 |
Why?
|
Odds Ratio | 1 | 2016 | 9661 | 0.010 |
Why?
|
Case-Control Studies | 1 | 2020 | 22248 | 0.010 |
Why?
|
Mass Screening | 1 | 2017 | 5454 | 0.010 |
Why?
|
Comorbidity | 1 | 2016 | 10580 | 0.010 |
Why?
|
Liver | 1 | 2017 | 7571 | 0.010 |
Why?
|
Cells, Cultured | 1 | 2017 | 18986 | 0.010 |
Why?
|
Models, Biological | 1 | 2017 | 9464 | 0.010 |
Why?
|
Neurons | 1 | 2017 | 9515 | 0.010 |
Why?
|
Risk Assessment | 1 | 2019 | 24299 | 0.010 |
Why?
|
Animals | 1 | 2017 | 168939 | 0.000 |
Why?
|
Concepts
(258)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(46)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_